Volume 10, Issue 4 (12-2022)                   J. Pediatr. Rev 2022, 10(4): 273-276 | Back to browse issues page


XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Ghaffari J. Biologic Drugs Treatment of Chronic Urticaria. J. Pediatr. Rev 2022; 10 (4) :273-276
URL: http://jpr.mazums.ac.ir/article-1-499-en.html
Department of Paediatrics, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran. , javadneg@yahoo.com
Abstract:   (309 Views)
Chronic Urticaria (CU) is a skin disorder characterized by wheal and flare with a duration of more than 6 weeks affecting 1%-2% of the population (more common in women). Thirty to 35% of cases of CU have angioedema [1]. The etiology of chronic spontaneous urticarial is not usually clear, 40%-50% are idiopathic and 30%-40% are autoimmune [2, 3]. Quality of life in CU is usually disturbed which has a direct relation with severity [4]. 
Full-Text [PDF 295 kb]   (142 Downloads) |   |   Full-Text (HTML)  (56 Views)  
Type of Study: Letter to the Editor | Subject: Allergy and Clinical Immunology
Received: 2022/10/9 | Accepted: 2022/10/12 | Published: 2022/12/19

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2023 CC BY-NC 4.0 | Journal of Pediatrics Review

Designed & Developed by : Yektaweb